News
The Heart Failure Drugs Market is poised for a transformative decade between 2025 and 2035. As heart failure continues to ...
Heart failure remains a significant global health challenge, affecting millions of people each year. It is a condition where ...
Cardiovascular effectiveness was observed, largely independent of age, in a cohort of older patients with type 2 diabetes.
VITAS recently became the first hospice provider to earn American Heart Association Heart Failure certification.
A large new study from Columbia University has found that one of the most commonly prescribed drugs for high blood pressure, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results